Comparison of automated home-cage monitoring systems: Emphasis on feeding behaviour, activity and spatial learning following pharmacological interventions

Journal of Neuroscience Methods

Volumn 234, Issue , 2014, Pages 13-25

  Robinson, Lianne ^a   Riedel, Gernot ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Food intake; Home cage; Locomotor activity; Mice; Spatial learning

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; APOMORPHINE; PHENCYCLIDINE; SCOPOLAMINE; AMINO ACID RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; SCOPOLAMINE BROMIDE;

ANIMAL EXPERIMENT; ARTICLE; AUTOMATED HOME CAGE MONITORING; COMPARATIVE STUDY; DRUG EFFECT; FEEDING BEHAVIOR; FOOD INTAKE; LOCOMOTION; MALE; MONITORING; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SPATIAL LEARNING; STRAIN DIFFERENCE; ANIMAL; C57BL MOUSE; DBA MOUSE; DEVICES; DOSE RESPONSE; DRUG EFFECTS; EXPLORATORY BEHAVIOR; FEMALE; HISTORY; INFORMATION PROCESSING; MOTOR ACTIVITY; PHYSIOLOGIC MONITORING; PHYSIOLOGY; PROCEDURES;

ANIMALS; APOMORPHINE; AUTOMATIC DATA PROCESSING; CHOLINERGIC ANTAGONISTS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; FEEDING BEHAVIOR; FEMALE; HISTORY, 20TH CENTURY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MONITORING, PHYSIOLOGIC; MOTOR ACTIVITY; PHENCYCLIDINE; PIPERIDINES; PYRAZOLES; SCOPOLAMINE HYDROBROMIDE; SPATIAL LEARNING;

EID: 84905380820     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2014.06.013     Document Type: Article

References (99)

1. Aghajanian G.K., Bunney B.S. Central dopaminergic neurons: neurophysiological identification and responses to drugs. Frontiers in catecholamine research 1973, 643-648. Pergamon, New York. S. Snyder, E. Usdin (Eds.).
2. Ahlander M., Misane I., Schott P.A., Ogren S.O. A behavioural analysis of the spatial learning deficit induced by the NMDA receptor antagonist MK-801 (dizocilpine) in the rat. Neuropsychopharmacology 1999, 21:414-426.
3. Ammassari-Teule M., Hoffmann H.J., Rossi-Arnaud C. Learning in inbred mice: strain-specific abilities across three radial maze problems. Behav Genet 1993, 23(4):405-412.
4. Ammassari-Teule M., Save E., de Marsanich B., Thinus-Blanc C. Posterior parietal cortex lesions severely disrupt spatial learning in DBA mice characterized by a genetic hippocampal dysfunction. Behav Brain Res 1998, 95(1):85-90.
5. Anisman H. Dissociation of disinhibitory effects of scopolamine: strain and task factors. Pharmacol Biochem Behav 1975, 3:613-618.
6. Bakshi V.P., Tricklebank M., Neijt H.C., Lehmann-Masten V., Geyer M.A. Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-d-aspartate receptor antagonists in rats. J Pharmacol Exp Ther 1999, 288:643-652.
7. Bartholomew Hodges D., Lindner M.D., Hogan J.B., Jones K.M., Markus E.J. Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity. Behav Pharmacol 2009, 20:237-251.
8. Battisti J.J., Uretsky N.J., Wallace L.J. Sensitization of apomorphine induced stereotyped behavior in mice is context dependent. Psychopharmacology 1999, 146:42-48.
9. Belknap J.K., Riggan J., Cross S., Young E.R., Gallaher E.J., Crabbe J.C. Genetic determinants of morphine activity and thermal responses in 15 inbred mouse strains. Pharmacol Biochem Behav 1998, 59(2):353-360.
10. Beraki S., Kuzmin A., Tai F., Ögren S.O. Repeated low dose of phencyclidine administration impairs spatial learning in mice: Blockade by clozapine but not by haloperidol. Eur Neuropsychopharmacol 2008, 18:486-497.
11. Beraki S., Diaz-Heijtz R., Tai F., Ogren S.O. Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice. Int J Neuropsychopharm 2009, 12:243-255.
12. Bertrand F., Lehmann O., Galani R., Lazarus C., Jeltsch H., Cassel J.C. Effects of MDL 73005 on water-maze performances and locomotor activity in scopolamine-treated rats. Pharm Biochem Behav 2001, 68:647-660.
13. Besheer J., Short K.R., Bevins R.A. Dopaminergic and cholinergic antagonismin a novel-object detection task with rats. Behav Brain Res 2001, 126:211-217.
14. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Arch Gen Psychiatry 1990, 47:181-188.
15. Bunney B.S., Aghajanian G.K., Roth R.H. Comparison of effects of ldopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurons. Nat New Biol 1973, 245:123-125.
16. Butcher S.P., Davis S., Morris R.G. A dose-related impairment of spatial learning by the NMDA receptor antagonist 2-amino-5-phosphonovalerate (AP5). Eur Neuropsychopharmacol 1990, 1:15-20.
17. Cabib S., Bonaventura N. Parallel strain-dependent susceptibility to environmentally induced stereotypies and stress-induced behavioral sensitization in mice. Physiol Behav 1997, 61:499-506.
18. Carey R.J., DePalma G., Damianopoulos E., Hopkins A., Shanahan A., Muller C.P., et al. Dopaminergic and serotonergic autoreceptor stimulation effects are equivalent and additive in the suppression of spontaneous and cocaine induced locomotor activity. Brain Res 2004, 1019:134-143.
19. Carrera M.P., Carey R.J., Dias F.R.C., de Mattos L.W. Memory re-consolidation and drug conditioning: an apomorphine conditioned locomotor stimulant response can be enhanced or reversed by a single high versus low apomorphine post-trial treatment. Psychopharmacology 2012, 220:281-291.
20. 1 receptor antagonist, AM251, causes a sustained reduction of daily food intake in the rat. Physiol Behav 2004, 82:863-869.
21. Chen R.Z., Frassetto A., Fong T.M. Effects of the CB1 cannabinoid receptor inverse agonist AM251 on food intake and body weight in mice lacking μ-opioid receptors. Brain Res 2006, 1108:176-178.
22. Chintoh A., Fulton J., Koziel N., Aziz M., Sud M., Yeomans J.S. Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M. Pharmacol Biochem Behav 2003, 76:53-61.
23. Crabbe J.C. Genetic differences in locomotor activation in mice. Pharmacol Biochem Behav 1986, 25(1):289-292.
24. Crawley J.N., Davis L.G. Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains. Brain Res Bull 1982, 8(6):609-612.
25. Crawley J.N., Belknap J.K., Collins A., Crabbe J.C., Frankel W., Henderson N., et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 1997, 132:107-124.
26. Day J., Damsma G., Fibiger H.C. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol Biochem Behav 1991, 38:723-729.
27. Deiana S., Platt B., Riedel G. The cholinergic system and spatial learning. Behav Brain Res 2011, 221(2):389-411.
28. Dellu F., Contarino A., Simon H., Koob G.F., Gold L.H. Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem 2000, 73(1):31-48.
29. de Visser L., van den Bos R., Kuurman W.W., Kas M.J.H., Spruijt B.M. Novel approach to the behavioural characterization of inbred mice: automated home cage observations. Genes Brain Behav 2006, 5:458-466.
30. de Visser L., van den Bos R., Stoker A.K., Kasb M.J.H., Spruijt B.M. Effects of genetic background and environmental novelty on wheel running as a rewarding behaviour in mice. Behav Brain Res 2007, 177:290-297.
31. Di Chiara G., Porceddu M.L., Fratta W., Gessa G.L. Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature 1977, 267:270-272.
32. Dodhart J.C., Mathis C., Ungerer A. Scopolamine-induced deficits in a two-trial object recognition task in mice. NeuroReport 1997, 8:1173-1178.
33. Edelsbrunner M.E., Painsipp E., Herzog H., Holzer P. Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake. Neuropeptides 2009, 43(6):491-497.
34. Galsworthy M.J., Amrein I., Kuptsov P.A., Poletaeva I.I., Zinn P., Rau A., et al. A comparison of wild-caught wood mice and bank voles in the IntelliCage: assessing exploration, daily activity patterns and place learning paradigms. Behav Brain Res 2005, 157(2):211-217.
35. Gardner A., Mallet P.E. Suppression of feeding, drinking and locomotion by a putative cannabinoid receptor 'silent antagonist'. Eur J Pharmacol 2006, 530:103-106.
36. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001, 156:117-154.
37. Gholamreza P., Pratt J.A., Nima D. Effects of low-dose scopolamine on locomotor activity: no dissociation between cognitive and non-cognitive effects. Neurosci Res Commun 2002, 31:165-174.
38. Gunzler S.A., Shakil S., Carlson N.E., Nutt J.G., Meshul C.K. Low doses of apomorphine transiently reduce locomotor activity in MPTP-treated mice. Neurosci Lett 2007, 428:64-67.
39. Harkin A., Kelly J.P., Frawley J., O'Donnell J.M., Leonard B.E. Test conditions influence the response to a drug challenge in rodents. Pharmacol Biochem Behav 2000, 65:389-398.
40. 9-tetrahydrocannabinol in humans. Psychopharmacology 2002, 164:407-415.
41. Hughes R.N., Desmond C.S., Fisher L.C. Room novelty, sex, scopolamine and their interactions as determinants of general activity and rearing, and light-dark preferences in rats. Behav Process 2004, 67:173-181.
42. Humby T., Laird F.M., Davies W., Wilkinson L.S. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur J Neurosci 1999, 11:2813-2823.
43. 9-tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test. Physiol Behav 2005, 86:475-479.
44. 9)-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test. Physiol Behav 2007, 90:425-430.
45. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20(3):201-225.
46. Jentsch J.D., Elsworth J.D., Redmond D.E., Roth R.H. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966. J Neurosci 1997, 17:1769-1775.
47. Kesslak J.P., Chuang K.R., Berchtold N.C. Spatial learning is delayed and brain-derived neurotrophic factor mRNA expression inhibited by administration of MK-801 in rats. Neurosci Lett 2003, 353:95-98.
48. Kinney G.G., Burno M., Campbell U.C., Hernandez L.M., Rodriguez D., Bristow L.J., et al. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents. J Pharmacol Exp Ther 2003, 306:116-123.
49. Klinkenberg I., Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 2010, 34:1307-1350.
50. 9-THC stimulates food intake in Lewis rats effects on chow, high-fat and sweet high-fat diets. Pharmacol Biochem Behav 2001, 68:539-543.
51. Krackow S., Vannoni E., Codita A., Mohammed A.H., Cirulli F., Branchi I., et al. Consistent behavioral phenotype differences between inbred mouse strains in the IntelliCage. Genes Brain Behav 2010, 9(7):722-731.
52. Kuribara H., Tadokoro S. Circadian variation in methamphetamine- and apomorphine-induced increase in ambulatory activity in mice. Pharmacol Biochem Behav 1982, 17(6):1251-1256.
53. Li Z., Boulesa B., Williams K., Peris J.A., Richelson E. The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex. Brain Res 2010, 1311:28-36.
54. Lightfoot J.T., Turner M.J., Daves M., Vordermark A., Kleeberger S.R. Genetic influence on daily wheel running activity level. Physiol Genomics 2004, 19:270-276.
55. Mandillo S., Rinaldi A., Oliverio A., Mele A. Repeated administration of phencyclidine, amphetamine and MK-801 selectively impairs spatial learning in mice: a possible model of psychotomimetic drug-induced cognitive deficits. Behav Pharmacol 2003, 14(7):533-544.
56. Marcais H., Protais P., Costentin J., Schwartz J.C. A gradual score to evaluate the climbing behaviour elicited by apomorphine in mice. Psychopharmacology 1978, 56:233-234.
57. Masuoka T., Fujii Y., Kamei C. Effect of scopolamine on the hippocampal theta rhythm during an eight-arm radial maze task in rats. Eur J Psychopharmacol 2006, 539:76-80.
58. Matsumoto K., Cai B., Sasaki K., Watanabe H.J. Methamphetamine and apomorphine-induced changes in spontaneous motor activity using a new system to detect and analyze motor activity in mice. Pharmacol Methods 1990, 24:111-119.
59. Matsumoto K., Cai B., Ohta H., Imamura L., Watanabe H. Apparent enhancement by SCH 23390 of apomorphine-induced locomotor activity in mice. Pharmacol Biochem Behav 1991, 39:699-703.
60. 1 antagonists SR 141716A and AM251 suppress food intake and food-reinforced behaviour in a variety of tasks in rats. Behav Pharmacol 2003, 14:583-588.
61. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol Rev 1998, 78:189-225.
62. Morita T., Sonoda R., Nakato K., Koshiya K., Wanibuchi F., Yamaguchi T. Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus. Psychopharmacology 2000, 148:281-288.
63. Mouri A., Noda Y., Enomoto T., Nabeshima T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem Int 2007, 51:173-184.
64. Myhrer T., Enger S., Aas P. Cognitive side effects in rats caused by pharmacological agents used to prevent soman-induced lethality. Eur J Pharmacol 2004, 483:271-279.
65. Nomura Y., Nishiyama N., Saito H., Matsuki N. Role of cholinergic neurotransmission in the amygdala on performances of passive avoidance learning in mice. Biol Pharm Bull 1994, 17:490-494.
66. Olney J.W., Newcomer J.W., Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatry Res 1999, 33:523-533.
67. Owen E.H., Logue S.H., Rasmussen D.L., Wehner J.M. Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience 1997, 80:1087-1099.
68. Paalzow G.H.M., Paalzow L.K. l-Dopa: how it may exacerbate parkinsonian symptoms. TIPS 1986, 9:15-19.
69. Paylor R., Baskall-Baldini L., Yuva L., Wehner J.M. Developmental differences in place-learning performance between C57BL/6 and DBA/2 mice parallel the ontogeny of hippocampal protein kinase C. Behav Neurosci 1996, 110(6):1415-1425.
70. Phillips T.J., Dickinson S., Burkhart-Kasch S. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behav Neurosci 1994, 108:789-803.
71. Platt B., Drever B., Koss D., Stoppelkamp S., Jyoti A., Plano A., et al. Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1. PLoS ONE 2011, 6(11):e27068.
72. Podhorna J., Brown R.E. Strain differences in activity and emotionality do not account for differences in learning and memory performance between C57BL/6 and DBA/2 mice. Genes Brain Behav 2002, 1(2):96-110.
73. Podhorna J., Didriksen M. Performance of male C57BL/6J mice and Wistar rats in the water maze following various schedules of phencyclidine treatment. Behav Pharmacol 2005, 16:25-34.
74. Riedel G., Fadda P., McKillop-Smith S., Pertwee R.G., Platt B., Robinson L. Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. Br J Pharmacol 2009, 156:1154-1166.
75. Robinson L., Plano A., Cobb S., Riedel G. Long-term home cage activity scans reveal lowered exploratory behaviour in symptomatic female Rett mice. Behav Brain Res 2013, 250:148-156.
76. Rowland N.E., Mukherjee M., Robertson K. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology 2001, 159:111-116.
77. Ryan D., Koss D., Porcu E., Woodcock H., Robinson L., Platt B., et al. Spatial learning impairments in PLB1 Triple knock-in Alzheimer mice are task-specific and age-dependent. Cell Mol Life Sci 2013, 70(14):2603-2619.
78. Shearman L.P., Rosko K.M., Fleischer R., Wang J., Xu S., Tong X.S., et al. Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav Pharmacol 2003, 14:573-582.
79. Sherwin C.M. Voluntary wheel running: a review and novel interpretation. Anim Behav 1998, 56:11-27.
80. Sipos M.L., Burchnell V., Galbicka G. Dose-response curves and time-course effects of selected anticholinergics on locomotor activity in rats. Psychopharmacology 1999, 147:250-256.
81. Sircar R. Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-d-aspartate receptor up regulation. Int J Dev Neurosci 2003, 21:159-167.
82. Spooren W.P.J.M., Vassout P., Waldmeier P., Gentsch C. Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity. Eur J Pharmacol 1998, 353:1-2.
83. Strombom U. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedebergs Arch Pharmacol 1976, 292:167-176.
84. Sturgeon R.D., Fessler R.G., Meltzer H.Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 1979, 59:169-179.
85. Theander-Carrillo C., Wiedmer P., Cettour-Rose P., Nogueiras R., Perez-Tilve D., Pfluger P., et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 2006, 116(7):1983-1993.
86. Trullas R., Skolnick P. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology 1993, 111(3):323-331.
87. Vago D.R., Bevan A., Kesner R.P. The role of the direct perforant path input to the CA1 subregion of the dorsal hippocampus in memory retention and retrieval. Hippocampus 2007, 17(10):977-987.
88. Vago D.R., Kesner R.P. Disruption of the direct perforant path input to the CA1 subregion of the dorsal hippocampus interferes with spatial working memory and novelty detection. Behav Brain Res 2008, 189:273-283.
89. Verty A.N.A., McGregor I.S., Mallet P.E. Consumption of high carbohydrate, high fat and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett 2004, 354:217-220.
90. 1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacol 2003, 167:103-111.
91. Voikar V., Koks S., Vasar E., Rauvala H. Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 2001, 72:271-281.
92. Wang C., McInnis J., Ross-Sanchez M., Shinnick-Gallagher P., Wiley J.L., Johnson K.M. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 2001, 107:535-550.
93. Wass C., Archer T., Palsson E., Fejgin K., Klamer D., Engel J.A., et al. Effects of phencyclidine on spatial learning and memory: nitric oxide-dependent mechanisms. Behav Brain Res 2006, 171:147-153.
94. White I.M., Minamoto T., Odell J.R., Mayhorn J., White W. Brief exposure to methamphetamine (METH) and phencyclidine (PCP) during late development leads to long-term learning deficits in rats. Brain Res 2009, 1266:72-86.
95. Wilcox R.E., Smith R.V., Anderson J.A., Riffee W.H. Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity. Pharmacol Biochem Behav 1980, 12:29-33.
96. Wiley J.L., Burston J.J., Leggett D.C., Alekseeva O.O., Razdan R.K., Mahadevan A., et al. CB1 cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol 2005, 145:293-300.
97. 9-THC and anandamide. Physiol Behav 2002, 76:241-250.
98. 9-THC hyperphagia by SR 141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 2002, 71:341-348.
99. Wittman G., Deli L., Kallo I., Hrabovszky E., Watanabe M., Liposits Z., et al. Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus. J Comp Neurol 2007, 503:270-279.